Meliora Therapeutics
PrivateLast Round
Seed
Sep 29, 2022
Total Funding Raised
$11M
Company Overview
Meliora Therapeutics is a biotechnology company that develops life-saving cancer therapies by using machine learning and a proprietary prediction atlas to identify the mechanisms of action of therapeutic molecules.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, ML Platforms, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meliora Therapeutics Comparables
Compare Meliora Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noetik | 80% | |
| Insilico Medicine | 73% | |
| Recursion Pharmaceuticals | 71% |
Meliora Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 29, 2022 |
Meliora Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Olive Capital | Seed |
| Global Village | Seed |
| ZhenFund | Seed |
| BrightEdge | Seed |
| Obvious Ventures | Seed |
| BrightEdge | Seed |
| Village Global | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2024
Grew 20% QoQ, from 15 to 18 employees.
- Feb 20, 2024
Grew 25% QoQ, from 12 to 15 employees.
Meliora Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Meliora Therapeutics's valuation, stock price, and market status.
Is Meliora Therapeutics a public or private company?
Meliora Therapeutics is a private company.
What is the current stock price of Meliora Therapeutics?
Meliora Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Meliora Therapeutics worth (valuation)?
Valuation information for Meliora Therapeutics is not publicly available.
Can I buy Meliora Therapeutics stock?
Meliora Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Meliora Therapeutics's last funding round?
Meliora Therapeutics's most recent funding round was Seed on September 29, 2022.
Who are the main investors in Meliora Therapeutics?
Key investors in Meliora Therapeutics include HOF Capital.
Will Meliora Therapeutics IPO soon?
No public IPO plans have been announced for Meliora Therapeutics.
How can I track Meliora Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Meliora Therapeutics's secondary market activity and sign up for updates.